Amiodarone in cardiac transplant waiting list patients with severe heart failure-Reference-Cited by-同舟云学术

Amiodarone in cardiac transplant waiting list patients with severe heart failure

Published:2017-06-23 Issue:2 Volume:19 Page:133-138
ISSN:2412-6160
Container-title:Russian Journal of Transplantology and Artificial Organs
language:
Short-container-title:RJTAO

Author:

Koloskova N. N.¹,Poptsov V. N.¹,Salikhova G. M.¹

Affiliation:

1. V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation

Abstract

Heart transplantation is the «gold standard» of severe heart failure treatment. Sudden arrhythmic death is the leading cause of death among these patients. Amiodarone is the only antiarrhythmic drug with beneficial effect on survival of patients with end-stage heart failure. Given its long half-life, pre-transplant use of amiodarone has been extensively discussed focusing on divergent results regarding morbidity and mortality after heart transplantation. Its adverse clinical events after transplantation remain debatable. This review is aimed at evaluation of the impact of amiodarone pretransplant use on mortality and complications after heart transplantation.

Publisher

V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs

Subject

Transplantation,Immunology and Allergy

Reference39 articles.

1. Hyoung-Seob Park, Yoon-Nyun Kim. Adverse effects of long-term amiodarone therapy. Korean J. Intern. Med. 2014; 29 (5): 571–573.

2. Pedersen CT, Kay GN, Kalman J. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014; 11 (10): 166–196.

3. January CT, Wann LS, Alpert JS. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2014; 64 (21): 1–76.

4. Saravanan P, Davidson NC. Risk assessment for sudden cardiac death in dialysis patients. Circ. Arrhythm. Electrophysiol. 2010; 3 (5): 553–559.

5. Jennings DL, Martinez B, Montalvo S, Lanfear DE. Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients. Heart Fail. Rev. 2015; 20 (5): 573–578.